Risk of cardiovascular disease with lipoprotein(a) in familial hypercholesterolemia: a review
Authors:
Open Access
- 11 July 2020
- journal article
- review article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science – Atherosclerotic Diseases
- Vol. 5 (1) , 148-152
Abstract
Introduction: Lipoprotein(a) (Lp[a]) is a risk factor of cardiovascular disease (CVD). Familial hypercholesterolemia (FH), which exhibits high low-density lipoprotein cholesterol (LDL-C) levels, is a risk factor of CVD. The relationship of Lp(a) with CVD has been characterized in populations specific to FH.Material and methods: Studies reporting on the relationship of Lp(a) with CVD among FH subjects via PubMed up to 2020 were reviewed.Results: Eight studies were identified as eligible. In the meta-analyses, a high Lp(a) level was significantly and predictively associated with CVD compared to a low Lp(a) level in 2 cross-sectional studies (odds ratio = 2.57; 95% confidence interval (CI): 1.16–5.73) and 6 cohort studies (risk/hazard ratio = 1.91; 95% CI: 1.50–2.43). The totally integrated relative risk of these studies was 1.97 (95% CI: 1.57–2.46).Conclusions: FH subjects with high Lp(a) levels can have a high CVD risk, and besides LDL-C, attention should be paid to Lp(a) levels in FH subjects.Keywords
This publication has 30 references indexed in Scilit:
- Lipoprotein(a) in the advent of a PCSK9 worldAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2019
- Lipoprotein(a) level associates with coronary artery disease rather than carotid lesions in patients with familial hypercholesterolemiaJournal of Clinical Laboratory Analysis, 2018
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansCirculation, 2016
- Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases – Some answers and still many questionsCritical Reviews in Clinical Laboratory Sciences, 2016
- Effect of therapeutic interventions on oxidized phospholipids on apolipoprotein B100 and lipoprotein(a)Journal of Clinical Lipidology, 2016
- Lipoprotein (a) and risk of cardiovascular disease--a systematic review and meta analysis of prospective studies.2011
- Lipoprotein(a) as a cardiovascular risk factor: current statusEuropean Heart Journal, 2010
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular MortalityJAMA, 2009
- Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Heterozygous Familial HypercholesterolemiaClinical Chemistry, 2005
- Lipoprotein(a) Levels in the Japanese Population: Influence of Age and Sex, and Relation to Atherosclerotic Risk Factors: The Jichi Medical School Cohort StudyAmerican Journal of Epidemiology, 1995